DexLab Overview

  • Status
  • Private
  • Latest Deal Type
  • Seed
  • (Cancelled)
  • Latest Deal Amount
  • $167K
Latest Deal Amount
  • Investors
  • 1

DexLab General Information

Description

Developer of a technology that allows to produce dextran from natural waste. The company's technology achieves this process by using molasses and milk whey, enabling doctors to decrease the volume of circulating blood plasma.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
  • Riga
  • Latvia
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DexLab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 06-Nov-2015 $167K Cancelled Startup
1. Accelerator/Incubator 14-Oct-2015 000.00 000.00 Completed Startup
To view DexLab’s complete valuation and funding history, request access »

DexLab Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Commercialization Reactor Accelerator/Incubator Minority 000 0000 000000 0
To view DexLab’s complete investors history, request access »